Intercepting Cancer

Watch to hear to an interactive dialogue about cancer prevention and early detection. Cancer prevention offers the best long-term strategy for saving lives while early-detection strategies are essential to ensuring better outcomes for patients. Dr. Sapna Syngal, Director of Research in the Center for Cancer Genetics and Prevention at Dana-Farber Cancer Institute, shares how precision prevention, a Dana-Farber priority, is changing the course of cancer. She discusses hereditary cancers, the implications of genetic testing, and the promise of new early detection strategies.

To learn more visit: The Revolutionary Science section of this site.

Give Now

Thank you for your interest in learning more about The Dana-Farber Campaign. You have been added to our email list and will receive updates on ways to join us in defying cancer. You can unsubscribe at any time.

There has been an issue submitting your request. Please try again.

Founded in Boston in 1947, Dana-Farber is a principal teaching affiliate of Harvard Medical School and a federally designated Comprehensive Cancer Center that develops and disseminates innovative patient therapies and scientific discoveries throughout the world. About Our Patient Stories: Dana-Farber shares patient stories which may include descriptions of actual medical results. Dana-Farber provides personalized care for each patient based on their unique needs; their experiences and results will vary.

At Dana-Farber we are committed to an inclusive community where human differences are valued and celebrated, and where all are welcome. We work every day to create an innovative, caring, and inclusive environment where each patient, family, and staff member feels valued and respected.